WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that it will report financial results for the third quarter of 2011 on Tuesday, November 1, 2011, after the U.S. financial markets close.